Insulin-like growth factor agonist molecules
US6750321B1 · kind B1 · utility
17Cited by
27References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 27, 2000 |
| Grant date | Jun 15, 2004 |
| Priority date | — |
| Expiry date | Feb 21, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/27
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptides are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist peptides are useful to increase serum and tissue levels of active IGFs in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.